Reprogramming of the Trypanosoma brucei epigenome during human infection

Dirk P Dittmer

Regulation of the KSHV Latent Promoter

Non-Hodgkin lymphoma Kaposi sarcoma

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Hematology and hematologic malignancies Pathology

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma Breast Brain, nervous system

Robert K Bradley

Genetic and molecular basis for SRSF2 mutations in myelodysplasia

Leukaemia

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma Breast

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Hematology and hematologic malignancies Pathology

Robert Kreitman

Development of Recombinant Toxins to Treat Hematologic Malignancies

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Omar Abdel-Wahab

Role of ASXL1 mutations in myeloid malignancies

Leukaemia